AIO0207-open-paren-a-close-paren-_3C: AIO0207(a), figure 3C

AIO0207(a)_3CR Documentation

AIO0207(a), figure 3C

Description

Kaplan-Meier digitized data from AIO0207(a), figure 3C (PMID 26361971). A reported sample size of 472 for a primary endpoint of time_tx_failure in colorectal cancer.

Usage

`AIO0207(a)_3C`

Format

A data frame of 314 observations and 3 variables:

time event time (in months)
event OS event indicator (0: no event, 1: event)
arm treatment arms (5fu_bev, no_tx)

Source

Hegewisch-Becker S, Graeven U, Lerchenmüller CA, et al. Maintenance strategies after first-line oxaliplatin plus fluoropyrimidine plus bevacizumab for patients with metastatic colorectal cancer (AIO 0207): a randomised, non-inferiority, open-label, phase 3 trial. Lancet Oncol 2015; 16: 1355–69.

Examples

summary(`AIO0207(a)_3C`)

kmplot(`AIO0207(a)_3C`)

raredd/kmdata documentation built on June 15, 2025, 9:33 a.m.